For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
The Epoch Times
What to Know About Trump’s Plan to Slash Drug Prices
The Epoch Times cited CEI’s expert on drug prices “Jeremy Nighohossian, a senior fellow at the Competitive Enterprise Institute, a libertarian think tank, told The…

Blog
GOP proposal includes reductions in health care expenditures
Over the weekend the House Committee on Energy and Commerce released a proposal describing how it would achieve the expenditure goals for the Reconciliation…

Blog
The numbers don’t add up in new Medicaid paper
In a recently released working paper, authors Angela Wyse and Bruce D. Meyer purport to show that the ACA Medicaid expansion saved 27,400 lives…
Search Posts
New York Post
Memo to critics: Only folks who don’t qualify will lose their Medicaid
Medicaid advocates are demanding the federal government to stop states from removing people from the program after 25 states and the District of Columbia dropped…
City Journal
Lab Leak: Likely
Three previously unreleased State Department cables, obtained by the public-health group U.S. Right to Know through a Freedom of Information Act lawsuit, confirm…
Washington Examiner
The Biden administration shouldn’t waste more taxpayer dollars on COVID vaccines
A Food and Drug Administration advisory committee recently voted to recommend updating the COVID-19 vaccine. But important questions remain: When…
Letters
CEI Joins Coalition Letter Supporting Efforts to Stop Tobacco Prohibitions in Ag Approps Bill
Chairwoman Granger and Ranking Member DeLauro, The undersigned organizations representing millions of consumers and taxpayers support Sections 768 and 769 of the Fiscal Year 2024…
National Review
Pharmaceuticals: Marching into Trouble
The National Institutes of Health recently rejected a request by private petitioners to exercise “march-in rights” under the 1980 Bayh-Dole Act to control the…
City Journal
Nature’s Vaccine
Public-health officials in the U.S., unlike their counterparts elsewhere, have steadfastly focused on Covid-19 vaccines in fighting the pandemic, acting as if natural immunity following…